⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylphenylsulfoxide SCHEMBL1332436 | 1.00 | — | — | |
| Methylphenylsulfoxide SCHEMBL31704585 | 1.00 | — | — | |
| Methylphenylsulfoxide SCHEMBL30837418 | 1.00 | — | — | |
| Methylphenylsulfoxide SCHEMBL3383118 | 1.00 | — | — | |
| Methylphenylsulfoxide SCHEMBL30374930 | 1.00 | — | — | |
| Methylphenylsulfoxide SCHEMBL110574 | 1.00 | — | — | |
| Methylphenylsulfoxide SCHEMBL28775312 | 0.97 | LMNA (0.33) | — | |
| Methylphenylsulfoxide SCHEMBL2343448 | 0.89 | OPRM1 (0.30) | — | |
| Methylphenylsulfoxide SCHEMBL28856188 | 0.89 | OPRM1 (0.30) | — | |
| SCHEMBL29402119 | 0.89 | OPRM1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117778339-A | Sulfoxide reductase mutant and application thereof in preparation of chiral sulfoxide and sulfinyl ester | 遵义医科大学 | 2024-03-29 | — | — | CN | disclosed |
| CN-117757763-A | Sulfoxide reductase mutant and application thereof in chiral sulfoxide preparation | 遵义医科大学 | 2024-03-26 | — | — | CN | disclosed |
| CN-115141814-B | Application of 4-hydroxyacetophenone monooxygenase | 江南大学 | 2023-05-05 | — | — | CN | disclosed |
| CN-115141814-A | Application of 4-hydroxyacetophenone monooxygenase | 江南大学 | 2022-10-04 | — | — | CN | disclosed |
| US-20210179554-A1 | ONIUM SALT COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-06-17 | — | — | US | disclosed |
| US-20200270225-A1 | Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex | INTREXON CORPORATION (US) | 2020-08-27 | — | — | US | disclosed |
| US-10633361-B2 | Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex | INTREXON CORPORATION (US) | 2020-04-28 | — | — | US | disclosed |
| US-9932305-B2 | Process for the asymmetric oxidation of organic compounds with peroxides in the presence of a chiral acid catalyst | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2018-04-03 | — | — | US | disclosed |
| US-9932305-B2 | Process for the asymmetric oxidation of organic compounds with peroxides in the presence of a chiral acid catalyst | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2018-04-03 | — | — | US | disclosed |
| US-20170204079-A1 | Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex | INTREXON CORPORATION (US) | 2017-07-20 | — | — | US | disclosed |
| WO-2013057251-A2 | HETEROARYL HYDROXAMIC ACID DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE | F. HOFFMANN-LA ROCHE AG (CH) | 2013-04-25 | — | — | WO | disclosed |
| US-20120316066-A1 | Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex | INTREXON CORPORATION (US) | 2012-12-13 | — | — | US | disclosed |
| US-20120116090-A1 | Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex | INTREXON CORPORATION (US) | 2012-05-10 | — | — | US | disclosed |
| US-8076517-B2 | Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex | INTREXON CORPORATION (US) | 2011-12-13 | — | — | US | disclosed |
| US-8076517-B2 | Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex | INTREXON CORPORATION (US) | 2011-12-13 | — | — | US | disclosed |
| US-20090163592-A1 | Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex | INTREXON CORPORATION (US) | 2009-06-25 | — | — | US | disclosed |
| US-20090163592-A1 | Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex | INTREXON CORPORATION (US) | 2009-06-25 | — | — | US | disclosed |
| US-7321070-B2 | Synthesis of isotopically labeled R- or S-[13C, 2H] glycerols | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2008-01-22 | — | — | US | disclosed |
| US-20050027146-A1 | Synthesis of isotopically labeled R- or S-[13C, 2H] glycerols | TRIAD NATIONAL SECURITY, LLC | 2005-02-03 | — | — | US | disclosed |
| WO-1993014084-A2 | PIPERIDINE DERIVATIVES | GLAXO GROUP LIMITED (GB) | 1993-07-22 | — | — | WO | disclosed |